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Abstract—The goal of this study was to investigate the use of 
custom-made orthopedic shoes (OS) and the association 
between the use of OS and the most relevant aspects of their 
usability. Over a 6-month period, patients meeting the inclusion 
criteria were recruited by 12 orthopedic shoe companies scat-
tered throughout the Netherlands and asked to complete a ques-
tionnaire composed of a pre- and post-OS section. Patients with 
different pathologies were included in the study (n = 339; 
response 67%). Mean age of the patients was 63 +/– 15 years, 
and 38% were male. Three months after delivery, 81% of the 
patients used their OS frequently (4–7 days/week), 13% occa-
sionally (1–3 days/week), and 6% did not use their OS. Associ-
ations were found between use and all measured aspects of 
usability (p-values varied from <0.001 to 0.028). Patients who 
used their OS more often had a more positive opinion regarding 
all the aspects of usability. We conclude that all aspects of the 
usability of OS are relevant in relation to their use and should be 
taken into account when prescribing and evaluating OS.
Key words: diabetes mellitus, foot disorders, medical devices, 
orthotics, patient satisfaction, rehabilitation, rheumatoid arthri-
tis, shoes, usability, use.
INTRODUCTION
Custom-made orthopedic shoes (OS) are used for a 
large variety of serious foot and/or ankle problems: for 
example, to prevent recurrence of foot ulcers, reduce 
plantar pressure, diminish pain in the feet or ankles dur-
ing standing and walking, support foot deformities, 
enhance mobility, or provide stability [1–3]. OS are pre-
scribed for patients with a wide range of disorders, such 
as diabetes, rheumatoid arthritis, degenerative foot disor-
ders, spasticity, and muscular diseases [3]. These patients 
do not fit standard off-the-shelf footwear. OS, including 
the insole, are completely individually designed and fab-
ricated from a positive model cast from the patient’s foot.
In order to be effective, OS must be used by those for 
whom they are prescribed. However, it has been frequently 
reported that patients do not use their OS [4–13]. Varying 
rates of nonuse have been reported, ranging from 20 to 25 
percent for first-time users [5,10] and from 4 to 19 percent 
for experienced users [4,6–9,11–13]. Generalization or 
comparison of the results of these studies is almost impos-
sible for three general reasons. First, most studies have 
been performed in one specific group of patients, which 
is different from the diversity seen in clinical practice. 
Abbreviations: ISO = International Organization for Stan-
dardization, MOS = Monitor Orthopedic Shoes, OS = custom-
made orthopedic shoes.
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after supply of the first pair of OS. Third, and most impor-
tant, use of OS has been defined in many different ways 
but mainly as in the following three main categories: fre-
quent, occasional, and nonuse. These categories have been 
analyzed using two main combinations (frequent + occa-
sional use vs nonuse [8,10,13] or frequent use vs occa-
sional + nonuse [5,7,9]), without any definitive rationale 
for the specific combination. Other studies define use in 
categories that are not clearly described and sometimes not 
mutually exclusive [4,11–12].
The use of OS has been associated with several 
aspects of their usability. Usability is “the extent to which 
a product can be used by specified users to achieve speci-
fied goals with effectiveness, efficiency, and satisfaction, 
in a specified context of use” (International Organization 
for Standardization [ISO], 9241-11). Within the domains 
of usability stated, a more positive score on any of the fol-
lowing aspects has been associated with a higher fre-
quency of use of OS: benefits of OS with regard to 
walking capacities, wound healing, or pain reduction 
(domain effectiveness); comfort and ease of use and the 
efficiency of the delivery process of OS (domain effi-
ciency); and cosmetic appearance and communication 
with the medical specialist or orthopedic shoe technician 
(domain satisfaction) [4–21]. However, only one study 
has been conducted in which the associations between use 
and aspects of all domains of usability have been studied 
and that was conducted only with patients with degenera-
tive disorders of the foot [10]. The focus of other studies 
has been on some aspects of one or two domains of 
usability and often in one specific group of patients only 
[4–9,11–21].
The aim of the present study was to investigate the 
use of OS in a group of patients that reflects the diversity 
seen in clinical practice and to investigate the associa-




A prospective cohort study with internal comparison 
was conducted. Over a 6-month period, patients meeting 
the inclusion criteria were recruited by 12 orthopedic 
shoe companies scattered throughout the Netherlands. A 
specially developed questionnaire comprising pre- and 
post-OS sections was used. After patients had given writ-
ten informed consent, during the visit at which foot meas-
urements were taken, the orthopedic shoe technician gave 
the pre-OS section to the patients. These patients’ per-
sonal data were sent to the researchers. The pre-OS sec-
tion had to be completed and returned to the researchers 
before actual delivery of the OS. Three months after 
delivery of the OS, the researchers sent the post-OS sec-
tion of the questionnaire to all patients who had previ-
ously completed the pre-OS section. However, in the 
current article, only analysis of the data acquired from the 
post-OS section of the questionnaire is presented.
Patients who did not complete either the pre- or post-
OS section of the questionnaire within a month were con-
tacted once by telephone by the researchers, who asked 
about the reason for the delay and possible problems and 
again asked the patients to complete the questionnaire.
Patients
A series of patients who were provided with their 
first-ever pair of OS by 12 Dutch orthopedic shoe compa-
nies was included. Patients who were previous users of 
OS were excluded because large differences exist 
between first-time and experienced users [7]. Other inclu-
sion criteria were (1) 16 years of age or older, (2) able to 
read Dutch, and (3) able to complete the questionnaire 
without help related to cognitive or physical impairments.
The patient flow chart is shown in the Figure. Mean 
age of the 339 patients included in the study was 63 ± 
15 years, and 38 percent were male. Of these patients, 85 
had diabetes mellitus, 60 rheumatoid arthritis, 237 a foot 
disorder, 23 a muscular disease, and 104 another disorder 
(e.g., cerebral vascular accident, spinal cord injury, psori-
asis, leather allergy, and others). Disorders were indicated 
by patient self-report, and it was possible to indicate more 
than one disorder. The age and sex of the patients included 
in the study were comparable with the nonresponders 
(patients who gave written informed consent but did not 
complete both sections of the questionnaire; mean age 
59 ± 17 years and 41% male) and with all patients of the 
12 orthopedic shoe companies to whom a first-ever pair of 
OS was provided between January and June 2007 (data 
obtained via administration system of the orthopedic shoe 
companies; mean age 63 ± 17 years and 39% male).
We were able to contact 34 of the 51 patients who did 
not respond to the post-OS section of the questionnaire. 
Reasons indicated for not responding were lack of interest 
(n = 15), lack of time (n = 10), not using OS and dissatisfied 
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ation (n = 2), questionnaire missing in post (n = 2), and no 
reason specified (n = 2).
Outcome Measures
We used the Monitor Orthopedic Shoes (MOS), 
which is a practical and reproducible questionnaire that 
can be used for a wide range of patients [22]. The MOS 
consists of a pre- and post-OS section. For the purposes of 
this study, we used only the post-OS section, which was 
designed to measure use and the most relevant aspects of 
usability of OS from a patient’s perspective through mul-
tiple choice and visual analog scale questions [22].
We defined three categories of use of OS: frequent 
use (4–7 days/week), occasional use (1–3 days/week), 
and nonuse (not using OS). We further asked patients to 
indicate the average daily duration of use in hours. Use of 
OS was not specified into activities during which OS 
were used or location of use (e.g., indoor vs outdoor).
Within the domains of usability as defined by the 
ISO, the following aspects were measured: change in 
walking capacity, wound healing, change in pain, and 
change in sprains (domain effectiveness); donning and 
Figure.
Flow chart of study participants. OS = custom-made orthopedic shoes.
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OS (domain efficiency); and cosmetics and communica-
tion with medical specialist and orthopedic shoe techni-
cian (domain satisfaction).
Statistical Analysis
We assessed differences between the three groups 
with a Kruskal-Wallis test. We used this test because of 
the nonnormal distribution of the data. We performed 
post hoc analyses to assess differences between the 
groups separately. We used a chi-square test for categori-
cal variables and calculated the effect size with Cramér’s 
V. We used a Mann-Whitney U-test for scale measures 
with a nonnormal distribution of the data and calculated 
the effect size with the formula (effect size = Z / (n1 + n2) 
[23]). Alpha level was set at p < 0.05. We analyzed data 
using SPSS for Windows, version 16.0 (SPSS Inc; Chi-
cago, Illinois).
RESULTS
Three months after delivery of OS, 81 percent of the 
patients used OS frequently (4–7 days/week), 13 percent 
used OS occasionally (1–3 days/week), and 6 percent did 
not use OS. No significant differences were found 
between the patient characteristics of the three groups 
(Table 1). Patients who use their OS frequently have a 
significantly higher daily duration of use than patients 
who use them occasionally (Table 1).
The associations between the use of OS and patients’ 
opinions with regard to aspects of the usability of OS are 
shown in Table 2. Significant differences between the 
three groups were found for all aspects of usability of OS, 
with a more positive score for patients who use their OS 
more often. The observations also indicate that more 
improvement was noted with regard to walking capacity in 
patients who frequently use their OS and that no differ-
ences were found with regard to wound healing, although a 
p-value could not be calculated for these aspects (Table 2). 
Considerable variation was present within the groups 
(Table 2).
Results of the post hoc analyses are shown in Table 3. 
Change in pain (both in the skin and in the muscles) and 
ease of walking with OS differed significantly between all 
groups. Both aspects of cosmetics (patient’s opinion and 
opinion of others) differed significantly between patients 
who frequently use their OS and both other groups and 
approached significance between patients who occasion-
ally use and those who do not use their OS. The largest 
effect sizes were found for ease of walking with OS and 
change in pain in the muscles. Finally, a significant effect 
for gender was found: compared with patients who fre-
quently use their OS, significantly more female patients 
did not use their OS. Because of this gender effect, two 
more post hoc analyses were performed. First, the associ-
ations between the use of OS and aspects of their usability 
were also calculated for the three groups of patients 
matched for gender. The results were the same: significant 
differences were found between the three groups for all 
aspects of usability (results not shown). Second, gender 
differences were calculated for all aspects of usability 
within the group of patients who frequently use their OS. 
No significant differences were found between the opin-
ion of men and women on any of the aspects of usability 
(results not shown).
DISCUSSION
In the present study, we found that 3 months after 
delivery, 81 percent of the patients used their OS fre-
quently, 13 percent occasionally, and 6 percent did not 
use their OS. All measured aspects of usability were 
associated with the use of OS; patients who use their OS 
more have a more positive opinion of the aspects of their 
usability. Comparison of these results with previous stud-
ies is almost impossible because in other studies patients 
with different pathologies were investigated, follow-up 
measurements were taken at different time points, and 
use was defined in various ways. In general, the rather 
small amount of nonuse found in this study supports the 
conclusion that nonuse of OS is not a major issue [7].
Even though nonuse of OS does not seem to be a 
major issue, gaining insight into factors associated with 
the frequency of use (and nonuse) is still relevant because 
of the high costs and efforts for the patient, the orthope-
dic shoe technician, and the medical specialist involved 
in every pair of OS. We measured aspects of usability 
within the domains effectiveness, efficiency, and satisfac-
tion. All these aspects of usability were positively associ-
ated with use. This result indicates that when prescribing 
and evaluating OS, prescribers should not focus on the 
effectiveness of OS alone: aspects of efficiency and satis-
faction are as important as effectiveness in relation to use 
of OS, which is in-line with  previous research [10].
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aspects of usability within the groups indicates that large 
individual differences exist. Some patients have extremely 
negative opinions about some aspects of the usability of 
their OS, yet still use them frequently. Others do not use 
their OS, despite a very positive opinion about some 
aspects of the usability. This finding may be explained by 
the importance that patients attach to specific aspects, a 
factor we did not take into account in our measurements. 
For example, for a patient with very severe pain, reduction 
of that pain may outweigh a negative opinion of the cos-
metics of the OS: the patient will use the OS every day. 
Whereas for another patient, the same pain reduction may 
still not outweigh a negative opinion of the cosmetics: the 
patient will not use the OS. Future research should take 
the importance that patients attach to specific aspects of 
OS usability into account. Clinically, this finding implies 
that it is essential to take all aspects of usability into 
account for every patient and find out which aspects (if 
any) are more important than others. The importance of 
structured evaluation in every individual has been stressed 
in recent Dutch research as well [6].
The present study has some limitations. First, we may 
have underestimated the rate of nonuse of OS. However, 
characteristics of patients included in the study were com-
parable with all patients who were provided with a pair of 
OS in that period and with nonresponders. Second, it 
could be hypothesized that patients who do not use their 
OS and have negative opinions of the usability of their OS 
are less willing to respond. To minimize this, we adminis-
tered the pre-OS section of the questionnaire in an early 
stage of the process, approximately 3 months before 
Table 1.
Patient characteristics, categorized with regard to frequency of use of their custom-made orthopedic shoes (OS).
Variable Frequent Use(81%, n = 275)
Occasional Use
(13%, n = 43)
Nonuse
(6%, n = 21) p-Value
*
Sex
Male 40 (110) 37 (16) 14 (3) 0.061
Female 60 (165) 63 (27) 86 (18)
Age (yr), Mean ± SD 63 ± 14 63 ± 17 63 ± 12 0.998
Main Reason†
Pain 54 (147) 70 (30) 57 (12) NA‡
Wounds 9 (25) 2 (1) 0 (0)
Foot Deviation 23 (62) 12 (5) 19 (4)
Leg Length Difference 3 (7) 0 (0) 10 (2)
Other 12 (34) 16 (7) 14 (3)
General Health§
Improved 19 (51) 7 (3) 29 (6) NA‡
No Change 71 (194) 79 (34) 52 (11)
Deteriorating 10 (28) 12 (5) 14 (3)
Missing 1 (2) 2 (1) 5 (1)
Daily Duration of Use (hours/day)
>12 24 (65) 5 (2) NA <0.001¶
8–12 34 (93) 2 (1) NA
4–8 30 (83) 33 (14) NA
1–4 11 (29) 47 (20) NA
<1 1 (1) 14 (6) NA
Missing 1 (4) 0 (0) NA
Note: Values are % (n) or otherwise as indicated. Frequent Use = using OS 4–7 days/week, Occasional Use = using OS 1–3 days/week, Nonuse = not using OS. Per-
centages may not add to 100 because of rounding.
*p-Value for differences between three groups on that aspect is shown.
†Main reason was indicated by patient self-report.
‡Chi-square test was not applicable because more than 25% of cells had expected count <5.
§General health refers to change in general health (not feet specifically) between pre- and postmeasurements.
¶p-Value for difference between frequent and occasional users only is shown: this value was not applicable (NA) for nonusers.
SD = standard deviation.
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likely related to dissatisfaction with use and aspects of the 
usability of OS. Not responding to the post-OS section of 
the questionnaire was more likely to be related to dissatis-
faction with the use and usability of OS. We therefore 
called these patients and were able to contact more than 
half of them. Only a few did not use their OS and even 
fewer did not respond because of dissatisfaction; all other 
Table 2.
Association between use of custom-made orthopedic shoes (OS) and aspects of their usability within domains effectiveness, efficiency, and 
satisfaction.
Variable Frequent Use(81%, n = 275)
Occasional Use
(13%, n = 43)
Nonuse




Improved, because of OS 76 (208) 33 (14) 0 (0) NA†
Improved, not because of OS 1 (3) 5 (2) 33 (7)
No change 14 (39) 47 (20) 33 (7)
Deteriorated, not because of OS 7 (18) 9 (4) 0 (0)
Deteriorated, because of OS 2 (4) 2 (1) 19 (4)
Missing 1 (3) 5 (2) 14 (3)
Wounds After OS‡
Patients with wounds before OS (n = 49, 10, 0)
More 4 (2) 10 (1) — NA†
Same 27 (13) 20 (2) —
Less 22 (11) 20 (2) —
Healed 47 (23) 50 (5) —
Patients with no wounds before OS (n = 226, 33, 21)
Wounds 6 (13) 6 (2) 0 (0) NA†
No wounds 94 (212) 94 (31) 71 (15)
Missing 0.5 (1) 0 (0) 29 (6)
Change in Pain (skin)§ (n = 166, 25, 8)‡ 82 (58.5–95) 66 (28.5–89.5) 22.5 (7.5–46) <0.001
Change in Pain (muscles) § (n = 212, 33, 9)‡ 79.5 (60–92) 58 (35–79.5) 20 (8–48) <0.001
Change in Sprains§ (n = 147, 23, 4)‡ 92 (75–97) 83 (50–96) 45.5 (31.25–78.75) 0.013
Efficiency
Donning/Doffing OS§ 75 (49.5–89) 63 (27.5–79.5) 51.5 (15.75–94.5) 0.017
Fit of OS§ 84 (68–95) 74 (38–89) 64 (36–89.5) 0.002
Ease of walking with OS§ 80 (62.25–92) 52 (31–81.5) 5 (4–17.5) <0.001
Weight of OS§ 48 (27–52) 26.5 (8.5–49.25) 17 (6.75–36.25) <0.001
Satisfaction
Cosmetics: patient’s opinion§ 58 (46–80) 49 (17–87) 16 (2.5–50.25) <0.001
Cosmetics: opinion of others
Ugly or very ugly 8 (22) 19 (8) 38 (8) <0.001
Neutral 37 (102) 47 (20) 19 (4)
Attractive or very attractive 40 (110) 19 (8) 10 (2)
Do not know or missing 15 (41) 16 (7) 33 (7)
Communication with doctor§ 85 (67.25–94) 79 (50–88) 53.5 (17–97.25) 0.028
Communication with ST§ 87 (64–94.75) 78 (41–90) 64 (15.5–96.25) 0.001
Note: Frequent Use = using OS 4–7 days/week, Occasional Use = using OS 1–3 days/week, Nonuse = not using OS. Values are % (n) or median (interquartile range). 
Percentages may not add to 100 because of rounding.
*p-Value for differences between three groups on that aspect is shown.
†Chi-square test was not applicable because more than 25% of cells had expected count <5.
‡Not all patients had wounds, pain, or sprains; therefore, number of patients for these questions is indicated for each use group, respectively.
§Scores could range from 0 (most negative score possible) to 100 (most positive score possible).
NA = not applicable, ST = orthopedic shoe technician.
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responding. Therefore, an underestimation of the rate of 
nonuse will, in our opinion, only be a small one.
A third limitation is that we could not perform multi-
variate analyses. There were two reasons for that. First, 
the MOS has two types of answer categories, which was 
a deliberate choice in the development of the question-
naire, during which emphasis was put on patients’ prefer-
ence [22]. Second, it was not possible to perform 
multivariate analyses on those parts of the aspects of 
usability with similar answer categories because of the 
(unexpectedly) large differences in the number of 
patients in the three groups: more than 80 percent of the 
patients were found in one group. Because of this imbal-
ance, it was not possible to investigate the importance of 
the aspects of usability relative to each other.
A general limitation in the field of research regarding 
use and usability of OS are the three differences between 
all studies with regard to (1) patients, (2) time period of 
follow-up, and (3) definition of use, which make compar-
ison of results almost impossible:
1. Studying patients with one specific disorder can be 
useful, yet may cause a problem when patients have 
multiple disorders, and it is not reflective of the diver-
sity seen in daily clinical practice. We therefore chose 
to include all patients, irrespective of disorder. Study-
ing patients with one specific disorder may be relevant 
in specialized settings, but information about comorbid 
disorders of the patients is then essential.
2. Time point of follow-up is crucial when interpreting 
the results and should be chosen with care. After deliv-
ery of OS, patients need about 2 months to get used to 
OS and wearing-out problems may occur after only 
4 months. We therefore chose to measure use after 
3 months. Also, a second pair of OS may be delivered 
after 5 months. In that case, the usability of each pair 
of OS should be evaluated separately, whereas the 
combined frequency of use is of most interest. Still, 
long-term follow-up is necessary to study whether 
short-term use will also result in long-term use.
3. Use can be defined based on frequency, duration, envi-
ronment, or task [24]. A definition based on frequency 
or duration is applicable for all patients, whereas a defi-
nition based on environment or task may change per 
individual and should always contain some information 
regarding the frequency or duration of use within that 
environment or task. We chose to define use based on 
frequency in order to be able to include a large group of 
Table 3.
Post hoc analyses on significant main effects of frequency of use of custom-made orthopedic shoes (OS) in domains of usability.
Variable Frequent Use × Nonuse Frequent Use × Occasional Use Occasional Use × Nonusep-Value* ES p-Value* ES p-Value* ES
Effectiveness
Change in pain (skin) <0.001 0.31 0.027 0.16 0.010 0.45
Change in pain (muscles) <0.001 0.26 <0.001 0.23 0.013 0.38
Change in sprains 0.013 0.20 0.081 0.13 0.109 0.31
Efficiency
Donning/doffing OS 0.145 0.09 0.010 0.15 0.974 0.00
Fit of OS 0.035 0.12 0.003 0.17 0.813 0.03
Ease of walking with OS <0.001 0.36 <0.001 0.22 <0.001 0.59
Weight of OS 0.001 0.22 <0.001 0.20 0.313 0.13
Satisfaction
Cosmetics: patient’s opinion <0.001 0.22 0.003 0.17 0.079 0.23
Cosmetics: opinion of others <0.001 0.34 0.004 0.20 0.066 0.33
Communication with doctors 0.094 0.11 0.025 0.13 0.464 0.10
Communication with ST 0.030 0.13 0.001 0.18 0.613 0.06
Patient Characteristics: Sex† 0.019 0.14 0.728 0.02 0.059 0.24
Note: Frequent Use = using OS 4–7 days/week, Occasional Use = using OS 1–3 days/week, Nonuse = not using OS. Nonsignificant results for patient characteris-
tics “age,” “main reason,” and “general health” not shown.
*p-Value for difference between groups is shown; significant difference indicates that patients who use their OS more often have a significantly more positive opin-
ion with regard to that aspect.
†Significant p-value indicates that men use their OS more frequently than women.
ES = effect size, ST = orthopedic shoe technician.
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most other studies only define two. In our opinion, a 
clinically relevant difference exists between these three 
groups. An obvious difference exists between patients 
who stop using OS and patients who use them. Keeping 
in mind that patients have to wear some kind of shoes 
every day, a relevant difference also exists between 
patients who use OS occasionally and those who use 
them frequently. We found large differences between all 
three groups, which supports our opinion. This finding 
also indicates that important information may be 
missed when only two categories of use are defined and 
compared. In future studies, use should preferably be 
defined based on frequency, with a distinction between 
frequent use, occasional use, and nonuse.
CONCLUSIONS
We conclude that the more positive opinion on all 
measured aspects of the usability of OS of patients who 
use their OS more often indicates that it is essential to 
take all aspects of the usability of OS into account when 
prescribing and evaluating OS. The effectiveness (e.g., a 
change in pain after OS), the efficiency (e.g., the ease of 
walking with OS), and the satisfaction (e.g., the patient’s 
opinion of the cosmetics of OS) are all relevant in rela-
tion to the use of OS.
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